首页> 外文OA文献 >Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patients

【2h】

Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patients

机译：miR-17，miR-21和miR-92的血清表达水平作为结肠癌患者佐剂化疗后复发的潜在生物标志物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nikolay V. Conev; Ivan S. Donev; Assia A. Konsoulova-Kirova; Trifon G. Chervenkov; Javor K. Kashlov; Krasimir D. Ivanov;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer [J] . Kim Chang Gon, Ahn Joong Bae, Jung Minkyu, Annals of surgical oncology . 2017,第1期

机译：术前血清癌胚抗原水平作为治疗切除后复发和存活后的预后因素，然后是III阶段结肠癌的佐剂化疗
2. LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy [J] . Szkandera J., Herzog S., Pichler M., The pharmacogenomics journal . 2015,第5期

机译：LGR5 rs17109924是结肠癌患者5-氟尿嘧啶辅助化疗治疗后复发时间的预测遗传生物标志物
3. Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5′fluoruracil-based adjuvant chemotherapy [J] . GiráldezM.D., LozanoJ.J., CuatrecasasM., International Journal of Cancer =: Journal International du Cancer . 2013,第5期

机译：用5'Fluorurcil的佐剂化疗治疗II期和III结肠癌患者肿瘤复发的基因表达特征
4. Adjuvant Chemotherapy Should Not Routinely Be Recommended to Patients with Stage II Colon Cancers that Manifest Microsatellite Instability [C] . Sigurdis Haraldsdottir, Richard M. Goldberg Gastrointestinal Cancers Symposium . 2014

机译：不应常规向患有阶段结肠癌的患者常规的辅助化学疗法，表明微卫星不稳定性
5. Adherence to adjuvant chemotherapy and post-treatment surveillance in a large community-based cohort of patients with colon cancer. [D] . Hu, Chung-Yuan. 2010

机译：在结肠癌患者的大型社区队列中坚持辅助化疗和治疗后监测。
6. Can Elevated Pretreatment Serum Carcinoembryonic Antigen Levels Serve as a Potential Biomarker Guiding Adjuvant Chemotherapy in Rectal Cancer Patients With ypTis-3N0 After Neoadjuvant Radiotherapy and Surgery? [O] . Chi Huang, Mingkun Jiang, Yan Li, 2021

机译：升高的预处理血清癌胚抗原水平是潜在的生物标志物在Neoadjuvant放射治疗和手术后的yptis-3n0患有直肠癌患者的辅助化疗吗？
7. Serum Expression Levels of miR-17, miR-21, miR-29a and miR-92 as Potential Biomarkers for Recurrence after Adjuvant Chemotherapy in Colon Cancer Patients //// Микрорибонуклеинови киселини miR-17, miR-21, miR-29a и miR-92 като потенциални маркери за оценка на риск от рецидив след адювантна химиотерапия при пациенти с карцином на колона [O] . Conev Nikolay 2016

机译：miR-17，miR-21，miR-29a和miR-92的血清表达水平作为结肠癌患者辅助化疗后复发的潜在生物标志物////微核糖核酸miR-17，miR-21，miR-29a和miR -92作为评估结肠癌患者辅助化疗后复发风险的潜在标志物

Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patients

著录项

引文网络

相似文献

相关主题

期刊订阅